Calcium channel blockers were linked to a marginally slower rate of visual field deterioration in glaucoma patients, though not clinically significant. The study involved a retrospective longitudinal ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

Treatment for coronary artery disease (CAD) involves lifestyle changes alongside medications such as antiplatelets and statins. There are many different medications to treat CAD. Treatment for CAD is ...

Use of systemic calcium channel blockers (CCBs) are associated with a slower rate of visual field (VF) deterioration in patients with glaucoma, according to research published in Ophthalmology ...

Bringing down high blood pressure reduces the risk of dementia and cognitive impairment, according to a large study of people in China. Many studies have linked high blood pressure, also known as ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.

Background: Dihydropyridine calcium channel blockers (DHCCBs) are effective first-line therapy for hypertension but can cause adverse effects (AEs) leading to the prescription of a new drug, i.e., a ...

Sodium channel blockers are medications that help reduce abnormal electrical activity in the heart. They can also lower the risk of severe complications such as stroke or sudden cardiac death. Sodium ...